Elucidation of the VDR-related genetic and molecular background of NAFLD pathophysiology may lead to new therapeutic approaches targeting NAFLD via vitamin D-VDR signaling. The gene discussed is VDR; the disease is metabolic dysfunction-associated steatotic liver disease.